This Aclaris Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Alpha Vantage · Benzinga · · AI-summarised by FinFlash
Several top Wall Street analysts have downgraded their ratings for five major companies. Wedbush notably cut Aclaris Therapeutics, Inc. (NASDAQ:ACRS) from Outperform to Neutral, lowering its price target significantly. Other companies receiving downgrades include Stanley Black & Decker, Shoals Technologies Group, Tyson Foods, and IDACORP, with adjusted price targets reflecting the revised outlooks.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.